Healthcare
Hospital build-out and expansion, diagnostic chains, and the equipment inside both.
A credit team that underwrites a hospital the way it underwrites a manufacturer arrives at the wrong tenor and a moratorium that ends in the middle of the ramp.
ICRA hospital sector outlook, July 2025 (eleven listed and two large unlisted chains); reporting on the Haryana PM-JAY suspension, August 2025. The bed figure is a July 2025 rating view and moves with the cycle.
The capex clock
ICRA moved its hospital outlook to Positive in July 2025, counting roughly 14,500 beds being added across FY2026 and FY2027 at ₹30,000–32,000 crore of capex. Read as a promoter rather than an analyst, that is a schedule: those beds are already financed, and they arrive in the catchment whether or not you expand.
The terms available while the outlook is Positive — tenor, moratorium, the willingness to underwrite a ramp rather than a construction period — are the terms that disappear when it turns. The question is whether the facility is negotiated inside this cycle.
Why this is not generic corporate debt
A new block is a construction-and-ramp exposure — 18 to 30 months from first pour to an occupancy that services debt, against a moratorium usually sized to construction alone, so amortisation begins while the block is still filling. A diagnostic chain is a rollout instead, where the credit turns on the unit economics of the most recent ten centres rather than the first ten.
The collateral position is weaker than the asset base suggests. Installed equipment is poor security: a linear accelerator sits in a bunker built around it, the resale market is thin, and de-installation consumes a real share of any recovery. Land is often held by a trust rather than by the operating company, which changes who can create a mortgage. And what produces the revenue — the licence, the accreditation, the consultants — cannot be charged at all. Hence DSCR and personal guarantee rather than security cover.
Licences also attach to a machine and a site rather than to the entity: an AERB licence is tied to that machine at that location, so security over an installed machine cannot simply be moved, and a PCPNDT breach can have an ultrasound machine sealed.
What the payer pays, and when
Cash patients settle at discharge. Insurers and TPAs settle 30 to 90 days later, net of deductions argued case by case. Government schemes pay on an administrative cycle no hospital controls. Payer mix, not seasonality, decides the cash cycle — and it is the part of a file most often shown as a pie chart rather than as an ageing.
In August 2025 around 650 private hospitals in Haryana suspended PM-JAY services over ₹490 crore of dues pending six to nine months, against a norm of payment within fifteen days of claim approval. A file carrying scheme receivables at book value, without the ageing behind them, asks a credit team to take the fifteen days on trust — and no credit team does.
Insurer receivables can also be repriced by negotiation, not only paid late, so a limit sized against merely slow receivables will not survive that. And administered rates move by circular: CGHS rates were revised with effect from 13 October 2025 and ECHS adopted them by order of 27 July 2026. A projection treating scheme rates as fixed for the life of a term loan is stale before the sanction letter is signed.
How the machine is actually underwritten
Equipment finance is a utilisation test wearing an asset-finance label. The machine is hypothecated and funded at roughly 75–90% of cost, and the test lenders describe applying is whether the EMI sits below about 25–30% of the incremental revenue that machine generates — indicative figures, a frame for what to model rather than a covenant. A utilisation ramp the file does not evidence is why a straightforward equipment loan comes back with a personal guarantee attached.
Accreditation is the item to sequence rather than to schedule, because it is the scoring gate for CGHS and ECHS empanelment, for insurer networks, and for the investor who reads it as shorthand.
Questions we answer in the first conversation
What DSCR will a lender accept on this specific machine, and what utilisation ramp does it want evidenced first?
How does our payer mix — cash, insurer, PM-JAY, CGHS, ECHS — change how much we can borrow, and against what security?
Where does the moratorium have to end for the repayment profile to match the ramp rather than the construction period?
At what point do we stop borrowing machine by machine and raise a structured facility instead?
Tell us what is fixed
The commissioning date, the equipment already ordered, the sanction condition you cannot clear, the empanelment the revenue plan assumes. Enough for us to say whether we are useful inside that window — and enough to say when we are not.
Answer the five questions